Feature Channels: Public Health

• share
• favorite_border

• share
• favorite_border

Researchers at Washington University School of Medicine in St. Louis have completed a clinical trial suggesting that the antidepressant drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.

• share
• favorite_border

A new national survey by The Ohio State University Wexner Medical Center finds that although a majority of Americans plan to take precautions at holiday gatherings, such as social distancing and asking those with COVID symptoms not to attend, many will also put themselves at risk.

• share
• favorite_border

The COVID-19 Research Symposium, hosted by the Mount Sinai Clinical Intelligence Center (MSCIC), is a one-day comprehensive review of advances in research by the Mount Sinai Health System to better understand and treat the coronavirus known as COVID-19.

• share
• favorite_border

• share
• favorite_border

In a study published today in Scientific Reports, a Nature Research Journal, a team of researchers led by Dr. Joseph Fisher presents a proof of concept of a simple method that could become a game-changer in rescue therapy for severe alcohol intoxication, as well as just “sobering up.”

• share
• favorite_border

An international team led by UCLA Fielding School of Public Health researchers has developed and tested two strategies for sustaining economic activity during the COVID-19 pandemic

• share
• favorite_border

Outcomes for COVID-19 patients two months after a stay in one of 38 Michigan hospitals include high rates of death, rehospitalization, lingering physical and mental health issues, problems with everyday activities and issues with work and finances.

• share
• favorite_border

People who have recovered from coronavirus can make potent antibodies to SARS-CoV-2 that evolve in the months after infection. These antibodies may be evolving in response to residual viral antigen hidden in the gut.

• share
• favorite_border

Researchers at Karolinska Institutet in Sweden have explored all COVID-19 research published during the initial phase of the pandemic.

• share
• favorite_border

• share
• favorite_border

High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.

• share
• favorite_border

Johns Hopkins Bloomberg School of Public Health has appointed Sean T. Allen, DrPH, as a Bloomberg Assistant Professor of American Health in the Department of Health, Behavior and Society.

• share
• favorite_border

• share
• favorite_border

A potential breakthrough in the early detection of the neck, head and anal cancers linked to human papilloma viruses (HPV) has emerged. It is based on a highly specific diagnostic test that appears to indicate cancer, and predict its course, from just a pinprick of blood.

• share
• favorite_border

Businesses can learn how to be proactive in reducing the spread of COVID-19 by improving indoor ventilation and mitigation strategies through South Dakota State University’s Economic Development Administration Center.

• share
• favorite_border

Published: November 10, 2020 | 3:47 pm | SHARE: There may be good news on the horizon regarding a COVID-19 vaccine.Pfizer and partner BioNTech reported that their trial vaccine appears to have a 90 percent efficacy rate, meaning that test subjects who received a vaccine experienced 90 percent fewer cases of symptomatic COVID-19 than those who received a placebo.

• share
• favorite_border

Seeking to develop effective interventions, researchers at University of California San Diego School of Medicine examined the psychological and environmental factors that lead to patterns of loneliness in different age groups.

• share
• favorite_border

Workers experiencing job and financial insecurity are less likely to follow the CDC's guidelines for COVID-19, such as physical distancing, limiting trips from home and washing hands, according to a Washington State University study.

• share
• favorite_border

The first COVID-19 vaccines could be authorised as early as the start of 2021.